The FDA warns that both CJC-1295 and ipamorelin are risky for immunogenicity, potentially causing life-threatening outcomes such as anaphylaxis.25 26 Cardiovascular concerns: Specifically concerning CJC-1295, the FDA warns of the risk of increased heart rate and systemic vasodilatory reaction, including flushing, warmth, and transient hypotension.25 27 Cancer: With their ability to increase the rate of cellular replication, growth hormone secretagogues in general are unsafe for cancer survivors and people with an active cancer diagnosis.28 Secretagogue use may elevate their risk for recurrence or worsen their prognosis
o En traitement d'entretien : une ampoule en IM par mois
Given that the global burden of diabetes is continuously increasing, it is estimated that the number of men in their reproductive age that will be affected with diabetes is likewise on the rise, as there is an elevation in the number of childhood and adolescent males with diabetes (144, 145)
EASL clinical practice guidelines on the management of hepatic encephalopathy
This allows the peptide to work directly on the affected area, promoting faster recovery and healing
Rest and activity modification typically resolve it
